The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies

The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies

Epilepsy is one of the most common neurological chronic disorders, with an estimated prevalence of 0. 5 – 1%. Currently, treatment options for epilepsy are predominantly based on the administration of symptomatic therapy. Most patients are able to achieve seizure freedom by the first two appropriate...

Full description

Bibliographic Details
Main Authors: Antonella Fattorusso, Sara Matricardi, Elisabetta Mencaroni, Giovanni Battista Dell'Isola, Giuseppe Di Cara, Pasquale Striano, Alberto Verrotti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Neurology
Subjects:
drug resistant epilepsy
pharmacoresistance
antiseizure medications (ASMs)
rational polytherapy
fenfluramine
cannabidiol
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.674483/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.674483/full

Similar Items